Search
for
Sort by
Research 541–570 of 1000+
- Improvement of androgenic alopecia by extracellular vesicles secreted from hyaluronic acid-stimulated induced mesenchymal stem cells
- Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
- Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature
- Back to the Roots—An Overview of the Chemical Composition and Bioactivity of Selected Root-Essential Oils
- Effectiveness of Extracellular Vesicle Application in Skin Aging Treatment and Regeneration: Do We Have Enough Evidence from Clinical Trials?
- Cold Plasma An emerging technology for clinical use in wound healing
- The Therapeutic Role of ADSC-EVs in Skin Regeneration
- Advances and Challenges in Plant Sterol Research: Fundamentals, Analysis, Applications and Production
- A decade of hair-loss clinical trials: a registry-based analysis of studies registered on ClinicalTrials.gov
- Table 1_A decade of hair-loss clinical trials: a registry-based analysis of studies registered on ClinicalTrials.gov.docx
- Multifunctional Silk Fibroin Hydrogel with Antibacterial and Regenerative Properties for Accelerated Wound Healing
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- Systematic Review of Platelet-Rich Plasma in Medical and Surgical Specialties: Quality, Evaluation, Evidence, and Enforcement
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- FDA Approved pediatric antihypertensive agents
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- FDA approves label addition for PDE-5 inhibitor
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Repurposing of Linagliptin Similar FDA Approved Drugs as Antidiabetic Agents
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- The US FDA has approved the marketing of generic finasteride 5mg tablets by Actavis.
- Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
- A microscopy-based small molecule screen in primary neurons reveals neuroprotective properties of the FDA-approved anti-viral drug Elvitegravir
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
- A Systematic Review and Meta-analysis of Randomized Controlled Trials of United States Food and Drug Administration-Approved, Home-use, Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology.